| scholarly article | Q13442814 |
| P2093 | author name string | Mansoor Amiji | |
| Husain Attarwala | |||
| P2860 | cites work | Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors | Q40158207 |
| Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery | Q40710606 | ||
| Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione | Q42808085 | ||
| Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease | Q45876830 | ||
| Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design | Q46842941 | ||
| Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS). | Q50686054 | ||
| Deactivation of macrophages by transforming growth factor-β | Q59068031 | ||
| Enhanced mucosal and systemic immune response with squalane oil-containing multiple emulsions upon intranasal and oral administration in mice | Q81186281 | ||
| Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract | Q24610060 | ||
| Macrophage activation and polarization | Q29616353 | ||
| The many faces of macrophage activation | Q29617449 | ||
| Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies | Q34063131 | ||
| Gene delivery with synthetic (non viral) carriers. | Q34403680 | ||
| Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease | Q34553476 | ||
| Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery | Q35190149 | ||
| Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery | Q35828034 | ||
| Gene therapy for autoimmune diseases: quo vadis? | Q35906093 | ||
| Towards safe, non-viral therapeutic gene expression in humans. | Q36068277 | ||
| Macrophages in inflammation | Q36230450 | ||
| Long-circulating polymeric nanovectors for tumor-selective gene delivery | Q36314788 | ||
| Polymeric nano- and microparticle technologies for oral gene delivery | Q36815912 | ||
| Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells | Q37065810 | ||
| IL-10: the master regulator of immunity to infection | Q37143028 | ||
| Progress in developing cationic vectors for non-viral systemic gene therapy against cancer | Q37171355 | ||
| IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach | Q37378185 | ||
| Macrophages and fibroblasts during inflammation, tissue damage and organ injury | Q37410537 | ||
| Enhancement in anti-proliferative effects of paclitaxel in aortic smooth muscle cells upon co-administration with ceramide using biodegradable polymeric nanoparticles | Q39982286 | ||
| P433 | issue | 6 | |
| P921 | main subject | nanoparticle | Q61231 |
| macrophage | Q184204 | ||
| P304 | page(s) | 1637-1649 | |
| P577 | publication date | 2012-01-27 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Multi-compartmental nanoparticles-in-emulsion formulation for macrophage-specific anti-inflammatory gene delivery | |
| P478 | volume | 29 |
| Q26343130 | Aerosol droplet delivery of mesoporous silica nanoparticles: a strategy for respiratory-based therapeutics |
| Q38136253 | Multifunctional nanoparticles for targeting cancer and inflammatory diseases. |
| Q39330117 | Oral nucleic acid therapy using multicompartmental delivery systems |
| Q38264691 | Targeted delivery systems for biological therapies of inflammatory diseases |
| Q38762655 | Transient Biocompatible Polymeric Platforms for Long-Term Controlled Release of Therapeutic Proteins and Vaccines |
| Q28548580 | Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases |
Search more.